Skip to main content
Premium Trial:

Request an Annual Quote

Celera Genomics Revenues and Losses Fall in Q2 of 2004

NEW YORK, Jan. 28 (GenomeWeb News) - Celera Genomics reported decreased revenues and net losses for its fiscal year 2004 second quarter today, accompanied by smaller R&D spending.

 

For the quarter ended Dec. 31, 2003, Celera Genomics, a unit of Applera, reported revenues of $19.2 million, compared to $22.9 million for the same period a year ago.

 

The company's net loss for the quarter totaled $13.6 million, or $0.19 per share, compared to $16.1 million, or $0.23 per share, in the prior year quarter.

 

Celera spent $25.2 million for R&D during the quarter, compared to $32.9 million the year before.

 

As of Dec. 31, 2003, Celera had cash and short term investments of about $770 milllion.

 

 

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.